SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Samrat Pharmachem - Quaterly Results

14 Nov 2022 Evaluate
A fair growth of 20.38% in the revenue at Rs. 711.18 millions was reported in the September 2022 quarter as compared to Rs. 590.76 millions during year-ago period.The Total revenue for the quarter ended September 2022 of  Rs. 59.12  millions  grew by 112.05% from Rs. 27.88 millions.The company reported a good operating profit of 84.16 millions compared to 42.25 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 711.18 590.76 20.38 1576.25 1063.12 48.27 2218.12 1790.18 23.90
Other Income 1.59 0.72 120.83 1.84 2.27 -18.94 5.51 4.63 19.01
PBIDT 84.16 42.25 99.20 213.27 58.03 267.52 248.92 91.31 172.61
Interest 2.36 2.07 14.01 4.62 3.81 21.26 6.74 12.77 -47.22
PBDT 81.80 40.18 103.58 208.65 54.22 284.82 241.95 78.36 208.77
Depreciation 1.60 1.48 8.11 3.18 2.93 8.53 5.95 4.93 20.69
PBT 80.20 38.70 107.24 205.47 51.29 300.60 236.00 73.43 221.39
TAX 21.08 10.82 94.82 52.68 13.86 280.09 64.17 20.11 219.09
Deferred Tax -1.09 1.38 -178.99 -0.78 1.44 -154.17 0.28 2.88 -90.28
PAT 59.12 27.88 112.05 152.79 37.43 308.20 171.83 53.32 222.26
Equity 30.90 30.90 0.00 30.90 30.90 0.00 30.90 30.90 0.00
PBIDTM(%) 11.83 7.15 65.47 13.53 5.46 147.87 11.22 5.10 120.02

Samrat Pharmachem Share Price

198.75 0.45 (0.23%)
18-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1824.00
Dr. Reddys Lab 1267.80
Cipla 1355.80
Zydus Lifesciences 1074.30
Lupin 2327.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: